Spots Global Cancer Trial Database for stereotattic ablation radiotherapy (sabr)
Every month we try and update this database with for stereotattic ablation radiotherapy (sabr) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer | NCT05815927 | Oligometastatic... | Pembrolizumab stereotattic ab... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC |